Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China

HONG KONG, Jun 26, 2026 – (ACN Newswire) – June 26, 2026, Everest Medicines today...